Abstract:The amyloid β-peptide (Aβ) of Alzheimer's disease (AD) is generated by proteolysis within the transmembrane domain (TMD) of a C-terminal fragment of the amyloid β protein-precursor (APP CTFβ) by the γ-secretase complex. This processing produces Aβ ranging from 38 to 49 residues in length. Evidence suggests that this spectrum of Aβ peptides is the result of successive γ-secretase cleavages, with endoproteolysis first occurring at the ε sites to generate Aβ48 or Aβ49, followed by C-terminal trimming mostly every three residues along two product lines to generate shorter, secreted forms of Aβ: the primary Aβ49-46-43-40 line and a minor Aβ48-45-42-38 line. The major secreted Aβ species are Aβ40 and Aβ42, and an increased proportion of the longer, aggregation-prone Aβ42 compared to Aβ40 is widely thought to be important in AD pathogenesis. We examined TMD substrate determinants of the specificity and efficiency of ε site endoproteolysis and carboxypeptidase trimming of CTFβ by γ-secretase. We determined that the C-terminal negative charge of the intermediate Aβ49 does not play a role in its trimming by γ-secretase. Peptidomimetic probes suggest that γ-secretase has S1', S2', and S3' pockets, through which trimming by tripeptides may be determined. However, deletion of residues around the ε sites demonstrates that a depth of three residues within the TMD is not a determinant of the location of endoproteolytic ε cleavage of CTFβ. We also show that instability of the CTFβ TMD helix near the ε site significantly increases endoproteolysis, and that helical instability near the carboxypeptidase cleavage sites facilitates C-terminal trimming by γ-secretase. In addition, we found that CTFβ dimers are not endoproteolyzed by γ-secretase. These results support a model in which initial interaction of the array of residues along the undimerized single helical TMD of substrates dictates the site of initial ε cleavage and that helix unwinding is essential for both endoproteolysis and carboxypeptidase trimming.

The Transmembrane Domain of the Alzheimer's Beta-Secretase (BACE1) Determines Its Late Golgi Localization and Access to Beta -Amyloid Precursor Protein (APP) Substrate.

Distinct Transcriptional Regulation and Function of the Human Bace2 and Bace1 Genes

Transmembrane Substrate Determinants for Γ-Secretase Processing of APP CTFβ

Alzheimer's Β-Secretase (BACE1) Regulates the Camp/pka/creb Pathway Independently of Β-Amyloid.

Association of Γ-Secretase with Lipid Rafts in Post-Golgi and Endosome Membranes

Characterizing the transmembrane domains of ADAM10 and BACE1 and the impact of membrane composition

Lys203 and Lys382 Are Essential for the Proteasomal Degradation of BACE1

Γ-Secretase, Evidence for Multiple Proteolytic Activities and Influence of Membrane Positioning of Substrate on Generation of Amyloid Β Peptides of Varying Length

Transcriptional Regulation of BACE1, the -Amyloid Precursor Protein -Secretase, by Sp1

BACE1 and BACE2 enzymatic activities in Alzheimer's disease.

BACE1 Gene Expression and Protein Degradation.

Transcriptional Regulation of BACE1, the Β-Amyloid Precursor Protein Β-Secretase, by Sp1

BACE2 Degradation is Mediated by Both the Proteasome and Lysosome Pathways

GGA Proteins Mediate the Recycling Pathway of Memapsin 2 (BACE).

Control of App Processing and A Beta Generation Level by Bace1 Enzymatic Activity and Transcription

Regulatory Role Of Golgi Brefeldin A Resistance Factor-1 In Amyloid Precursor Protein Trafficking, Cleavage And A Beta Formation

Proteolysis of Chimeric β-Amyloid Precursor Proteins Containing the Notch Transmembrane Domain Yields Amyloid β-like Peptides

Detection of Bace Cleavage in the Secretary Pathway

Endoplasmic Reticulum and Trans-Golgi Network Generate Distinct Populations of Alzheimer Beta-Amyloid Peptides

BACE2, As a Novel APP Θ‐secretase, is Not Responsible for the Pathogenesis of Alzheimer's Disease in Down Syndrome

Beta Secretase Localization, Amyloid Deposition And Aberrant Synaptic And Neuritic Sprouting In Transgenic Mouse Alzheimer Models: A Role For Bace1 In Synaptic Remodeling And Plaque Formation?